[ad_1]
Steve O’Hear / TechCrunch:
London-primarily based LabGenius, which makes use of AI and &ldquorobotic automation&rdquo for protein drug discovery, raises $10M Series A led by Lux Capital and Apparent Ventures  &mdash  LabGenius, a London-primarily based startup applying AI and &ldquorobotic automation&rdquo to protein drug discovery, has raised $10 million in Series A funding.
[ad_2]
